08/21/2025
8:32 PM | Arcutis Biotherapeutics (Issuer)
Burnett Patrick (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/21/2025
4:27 PM | Arcutis Biotherapeutics (Subject)
Burnett Patrick (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
08/20/2025
4:19 PM | Arcutis Biotherapeutics (Subject)
Frazier Life Sciences VIII, L.P. (Filed by)
| Form SCHEDULE 13D/A | |
08/14/2025
7:04 AM | Arcutis Biotherapeutics (Subject)
Polar Capital Holdings Plc (Filed by)
| Form SCHEDULE 13G/A | |
08/08/2025
3:40 PM | Arcutis Biotherapeutics (Subject)
Topper David Joseph (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
08/06/2025
2:04 PM | Arcutis Biotherapeutics (Subject)
Topper David Joseph (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
08/05/2025
5:28 PM | Arcutis Biotherapeutics (Issuer)
Welgus Howard G. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/05/2025
5:28 PM | Arcutis Biotherapeutics (Issuer)
Matsuda Masaru (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/05/2025
5:28 PM | Arcutis Biotherapeutics (Issuer)
Vairavan Latha (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/05/2025
5:28 PM | Arcutis Biotherapeutics (Issuer)
Burnett Patrick (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/05/2025
5:29 PM | Arcutis Biotherapeutics (Issuer)
Watanabe Todd (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
Get the Latest News and Ratings for ARQT and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Arcutis Biotherapeutics and its competitors with MarketBeat's FREE daily newsletter. |
08/04/2025
2:38 PM | Arcutis Biotherapeutics (Subject)
Vairavan Latha (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
08/04/2025
2:40 PM | Arcutis Biotherapeutics (Subject)
Matsuda Masaru (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
08/04/2025
2:42 PM | Arcutis Biotherapeutics (Subject)
Burnett Patrick (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
08/04/2025
2:43 PM | Arcutis Biotherapeutics (Subject)
Watanabe Todd (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
07/14/2025
3:02 PM | Arcutis Biotherapeutics (Issuer)
Burnett Patrick (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/14/2025
11:27 AM | Arcutis Biotherapeutics (Subject)
Burnett Patrick (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
07/10/2025
2:55 PM | Arcutis Biotherapeutics (Subject)
Burnett Patrick (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
07/01/2025
9:12 AM | Arcutis Biotherapeutics (Subject)
Welgus Howard G. (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
06/20/2025
3:32 PM | Arcutis Biotherapeutics (Issuer)
Welgus Howard G. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/18/2025
1:09 PM | Arcutis Biotherapeutics (Subject)
Welgus Howard G. (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
06/17/2025
4:45 PM | Arcutis Biotherapeutics (Issuer)
Heron Patrick J (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/17/2025
3:52 PM | Arcutis Biotherapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/16/2025
7:16 PM | Arcutis Biotherapeutics (Issuer)
CHAUDHURI BHASKAR (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/16/2025
7:17 PM | Arcutis Biotherapeutics (Issuer)
Gilbert Halley E (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/16/2025
7:17 PM | Arcutis Biotherapeutics (Issuer)
Krishnamohan Neha (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/16/2025
7:17 PM | Arcutis Biotherapeutics (Issuer)
Curran Terrie (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/16/2025
7:17 PM | Arcutis Biotherapeutics (Issuer)
Leonard Keith R (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/16/2025
7:17 PM | Arcutis Biotherapeutics (Issuer)
Heron Patrick J (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/16/2025
7:17 PM | Arcutis Biotherapeutics (Issuer)
Welgus Howard G. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/16/2025
7:18 PM | Arcutis Biotherapeutics (Issuer)
LIN SUE-JEAN (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/12/2025
3:53 PM | Arcutis Biotherapeutics (Issuer)
Watanabe Todd Franklin (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/06/2025
7:44 AM | Arcutis Biotherapeutics (Issuer)
Heron Patrick J (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/29/2025
7:25 PM | Arcutis Biotherapeutics (Issuer)
Matsuda Masaru (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/20/2025
3:37 PM | Arcutis Biotherapeutics (Issuer)
Edwards Larry Todd (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/15/2025
4:41 PM | Arcutis Biotherapeutics (Subject)
PRUDENTIAL FINANCIAL INC (Filed by)
PRUDENTIAL FINANCIAL INC (Filed by)
| Form SCHEDULE 13G/A | |
05/09/2025
6:45 PM | Arcutis Biotherapeutics (Issuer)
Burnett Patrick (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/08/2025
4:59 PM | Arcutis Biotherapeutics (Subject)
JENNISON ASSOCIATES LLC (Filed by)
| Form SCHEDULE 13G/A | |
05/08/2025
1:54 PM | Arcutis Biotherapeutics (Subject)
Burnett Patrick (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
05/07/2025
6:27 PM | Arcutis Biotherapeutics (Issuer)
Vairavan Latha (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
05/07/2025
6:29 PM | Arcutis Biotherapeutics (Issuer)
Vairavan Latha (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
Altucher: It Looks Like My Trump prediction is coming true (Ad) New Hampshire just launched a Strategic Crypto Reserve — and James Altucher says it’s the first sign that “Trump’s Great Gain” has officially begun.
Altucher believes select cryptos could turn $900 into $108,000 over the next 12 months — and he’s laying out the full gameplan in a new presentation. See Altucher’s Trump crypto prediction here |
05/05/2025
3:49 PM | Arcutis Biotherapeutics (Issuer)
Welgus Howard G. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/02/2025
3:20 PM | Arcutis Biotherapeutics (Subject)
Matsuda Masaru (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
05/02/2025
3:20 PM | Arcutis Biotherapeutics (Subject)
Burnett Patrick (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
04/10/2025
4:15 PM | Arcutis Biotherapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/03/2025
3:21 PM | Arcutis Biotherapeutics (Issuer)
Topper David Joseph (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/03/2025
3:21 PM | Arcutis Biotherapeutics (Issuer)
Welgus Howard G. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/26/2025
3:41 PM | Arcutis Biotherapeutics (Issuer)
Watanabe Todd Franklin (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/24/2025
3:20 PM | Arcutis Biotherapeutics (Subject)
Watanabe Todd Franklin (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/20/2025
5:27 PM | Arcutis Biotherapeutics (Issuer)
Watanabe Todd Franklin (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/14/2025
3:19 PM | Arcutis Biotherapeutics (Subject)
Burnett Patrick (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/13/2025
4:10 PM | Arcutis Biotherapeutics (Subject)
Burnett Patrick (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/04/2025
6:43 PM | Arcutis Biotherapeutics (Issuer)
Matsuda Masaru (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/04/2025
6:43 PM | Arcutis Biotherapeutics (Issuer)
Edwards Larry Todd (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/04/2025
6:43 PM | Arcutis Biotherapeutics (Issuer)
Welgus Howard G. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/04/2025
6:43 PM | Arcutis Biotherapeutics (Issuer)
Topper David Joseph (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/04/2025
6:43 PM | Arcutis Biotherapeutics (Issuer)
Watanabe Todd Franklin (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/04/2025
6:44 PM | Arcutis Biotherapeutics (Issuer)
Burnett Patrick (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/04/2025
3:46 PM | Arcutis Biotherapeutics (Subject)
Watanabe Todd Franklin (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/04/2025
3:47 PM | Arcutis Biotherapeutics (Subject)
Burnett Patrick (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/03/2025
4:39 PM | Arcutis Biotherapeutics (Subject)
Watanabe Todd Franklin (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/03/2025
4:36 PM | Arcutis Biotherapeutics (Subject)
Burnett Patrick (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/03/2025
4:38 PM | Arcutis Biotherapeutics (Subject)
Matsuda Masaru (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/03/2025
3:50 PM | Arcutis Biotherapeutics (Subject)
Welgus Howard G. (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/25/2025
3:13 PM | Arcutis Biotherapeutics (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
02/04/2025
7:00 PM | Arcutis Biotherapeutics (Issuer)
Edwards Larry Todd (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/04/2025
7:00 PM | Arcutis Biotherapeutics (Issuer)
Burnett Patrick (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/04/2025
7:00 PM | Arcutis Biotherapeutics (Issuer)
Welgus Howard G. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/04/2025
7:01 PM | Arcutis Biotherapeutics (Issuer)
Watanabe Todd Franklin (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/04/2025
7:01 PM | Arcutis Biotherapeutics (Issuer)
Matsuda Masaru (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/03/2025
5:03 PM | Arcutis Biotherapeutics (Subject)
Matsuda Masaru (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/03/2025
5:04 PM | Arcutis Biotherapeutics (Subject)
Watanabe Todd Franklin (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/03/2025
5:01 PM | Arcutis Biotherapeutics (Subject)
Burnett Patrick (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/03/2025
5:02 PM | Arcutis Biotherapeutics (Subject)
Edwards Larry Todd (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/03/2025
4:10 PM | Arcutis Biotherapeutics (Subject)
Welgus Howard G. (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/13/2025
6:33 AM | Arcutis Biotherapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/02/2025
4:26 PM | Arcutis Biotherapeutics (Subject)
Welgus Howard G. (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
12/31/2024
5:13 PM | Arcutis Biotherapeutics (Issuer)
Burnett Patrick (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/31/2024
3:19 PM | Arcutis Biotherapeutics (Subject)
Burnett Patrick (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
12/23/2024
6:22 PM | Arcutis Biotherapeutics (Issuer)
Watanabe Todd Franklin (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/20/2024
4:02 PM | Arcutis Biotherapeutics (Subject)
Watanabe Todd Franklin (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
12/02/2024
3:25 PM | Arcutis Biotherapeutics (Subject)
Welgus Howard G. (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
11/26/2024
3:21 PM | Arcutis Biotherapeutics (Issuer)
Burnett Patrick (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/19/2024
6:52 PM | Arcutis Biotherapeutics (Issuer)
Matsuda Masaru (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/19/2024
3:25 PM | Arcutis Biotherapeutics (Subject)
Matsuda Masaru (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
11/18/2024
6:04 PM | Arcutis Biotherapeutics (Issuer)
Burnett Patrick (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/15/2024
3:31 PM | Arcutis Biotherapeutics (Subject)
Burnett Patrick (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
11/14/2024
6:50 PM | Arcutis Biotherapeutics (Subject)
Point72 Asset Management, L.P. (Filed by)
| Form SC 13G/A | |
11/13/2024
5:45 PM | Arcutis Biotherapeutics (Issuer)
Curran Terrie (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/13/2024
3:30 PM | Arcutis Biotherapeutics (Subject)
Rubric Capital Management LP (Filed by)
| Form SC 13G/A | |
11/12/2024
10:34 AM | Arcutis Biotherapeutics (Subject)
Curran Terrie (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
NVIDIA's Worst Nightmare? (Ad) $2 TRILLION Quantum Gold Rush
While everyone fights over expensive AI stocks... McKinsey just revealed the REAL fortune they expect to come from quantum computing - a $2 trillion explosion by 2035. The kicker? One company is America's FIRST commercial supplier of the material that makes it possible. Click here to learn how to get the ticker symbol <<< |
11/06/2024
3:07 PM | Arcutis Biotherapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
11/04/2024
3:41 PM | Arcutis Biotherapeutics (Subject)
Watanabe Todd Franklin (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
11/01/2024
1:51 PM | Arcutis Biotherapeutics (Subject)
Welgus Howard G. (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
10/22/2024
2:24 PM | Arcutis Biotherapeutics (Subject)
BlackRock, Inc. (Filed by)
| Form SC 13G/A | |
10/03/2024
3:55 PM | Arcutis Biotherapeutics (Issuer)
Edwards Larry Todd (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/03/2024
3:55 PM | Arcutis Biotherapeutics (Issuer)
Welgus Howard G. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/01/2024
2:32 PM | Arcutis Biotherapeutics (Subject)
Welgus Howard G. (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
09/25/2024
8:42 PM | Arcutis Biotherapeutics (Issuer)
Topper David Joseph (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/24/2024
2:51 PM | Arcutis Biotherapeutics (Subject)
Topper David Joseph (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
MarketBeat All Access